Psych Congress Year-Round

Psych Congress Steering Committee members discuss their favorite sessions and aspects of the 31st annual conference, held in Orlando, Fla. Oct. 25-28, 2018.

Articles

ORLANDO, Fla.—The opening session of the 31st annual Psych Congress gave attendees a detailed view of the ways in which psychedelic compounds such as psilocybin and LSD affect the brain and how they could be used in psychiatric practice.

ORLANDO, Fla.­—The kickoff keynote address at the annual Psych Congress conference has been named after former Steering Committee member Eric C. Arauz, MLER, who passed away at age 47 this year.

ORLANDO, Fla.—Two descriptions of depression presented at the Psych Congress 2018 preconference appeared to have little in common. But they were actually the same tale, told from vastly different points of view.

Anna Lembke, MD

Q&A: Psychiatrist Anna Lembke, MD, discusses the state of the US prescription drug epidemic, our modern-day aversion to pain of all forms, and how her medical colleagues have reacted to her book’s provocative title.

Robin Carhart-Harris, PhD

Q&A: Psych Congress Featured Speaker Robin Carhart-Harris, PhD, addresses misconceptions surrounding psychedelics and discusses their potential therapeutic utility.

Pages

Blogs

BLOG: This passing remark about fearing that others would find out that I was unprepared and unqualified generated more questions and sidebar conversations than anything else I discussed at Elevate.

BLOG: Those of us who work in health care are undoubtedly well aware of the problems that can ensue when patients don’t follow up on recommended treatment.

BLOG: In a field as complex as psychiatry, where no one person can know everything about every facet of the discipline, we are bound to have deficiencies in our knowledge.

Pages

Posters

Roger McIntyre, MD, FRCPC; Philip Harvey, PhD; Carl Gommoll, MS; Changzheng Chen, PhD; Kenneth Kramer, PhD; Keith Wesnes, PhD
Kruti Joshi, MPH; Neeta Tandon, PhD; Dominic Pilon, MA; Marie-Hélène Lafeuille, MA; Rhiannon Kamstra, MSc; Bruno Emond, BSc; Patrick Lefebvre, MA
Patrick Lefebvre, MA; Erik Muser, PharmD, MPH; Kruti Joshi, MPH; Maral DerSarkissian, PhD; Rachel Bhak, MS; Mei Duh, ScD, MPH; Brian Shiner, MD, MPH; Yinong Young-Xu, ScD, MS, MA

Pages

Video

Schizophrenia long-acting injectables

This video is a component of an accredited CME session presented at Elevate by Psych Congress 2017.

The educational activity is supported by educational grants from Alkermes, Inc. and Otsuka America Pharmaceuticals, Inc.

Long-acting injectables schizophrenia

This video is a component of an accredited CME session presented at Elevate by Psych Congress 2017.

The educational activity is supported by educational grants from Alkermes, Inc. and Otsuka America Pharmaceuticals, Inc.

Jeffrey Swanson, PhD, speaks about the prevalence of serious mental illness in the US. Dr. Swanson is Professor in Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina.

Pages